arrow
Q

Qiang Wei

Naval Medical University
H指数:20
被引数:1,260
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mesenchymal Stem Cells Restore Endometrial Integrity and Sustain Pregnancy via CCR7-ERK/JNK Signaling Modulation
2026-01-160
OAAI
Comparative study on the clinical efficacy of femoral neck system and cannulated cancellous screw in the treatment of femoral neck fractures in young patients

年轻患者股骨颈骨折治疗中股骨颈系统与空心松质骨螺钉的临床疗效比较研究

2025-12-120
PRE
Analysis of screen-detected pulmonary nodules before and after the novel coronavirus epidemic: a multicenter retrospective cohort study

新型冠状病毒疫情前后筛查发现的肺结节分析:一项多中心回顾性队列研究

2025-04-010
OAAI
No-touch recipient hepatectomy in liver transplantation for liver malignancies: A state-of-the-art review
2025-02-012
PRE
FGF21 modulates immunometabolic homeostasis via the ALOX15/15-HETE axis in early liver graft injury
2024-10-030
OA
The roles of tertiary lymphoid structures in genitourinary cancers: molecular mechanisms, therapeutic strategies, and clinical applications

三级淋巴结构在泌尿生殖系统肿瘤中的作用:分子机制、治疗策略与临床应用

2024-08-010
OAAI
Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21-Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis
2024-02-154
OAAI
Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression
2023-12-015
PRE
Incorporation of protein induced by vitamin K absence or antagonist-II into transplant criteria expands beneficiaries of liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study in China

将维生素k缺乏或拮抗剂-II诱导的蛋白质纳入移植标准扩大了肝细胞癌肝移植的受益者: 中国多中心回顾性队列研究

2023-11-215
OAAI
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development

用细胞因子等武装car-t细胞: 第四代car-t开发中的创新

2023-11-0118
OAAI
Dynamic immune cell profiling identified natural killer cell shift as the key event in early allograft dysfunction after liver transplantation
2023-10-314
OAAI
BMI1-induced CD127+KLRG1+memory T cells enhance the efficacy of liver cancer immunotherapy
2023-09-017
PRE
Cell therapy in end-stage liver disease: replace and remodel
2023-05-2513
OAAI
SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment
2023-01-0324
PRE
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road

免疫治疗与肝移植联合应用于肝细胞癌:一条坎坷但充满希望的道路

2023-01-0110
OA
Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence
2023-01-013
OA
Liver transplantation for hepatocellular carcinoma arising in noncirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China
2023-01-010
OA
Preventive use of low molecular weight heparin in portal vein system thrombosis after splenectomy without portal hypertension
HELIYON
IF3.6
2022-12-010
OAAI
The critical role of therapeutic plasma exchange in ABO-incompatible liver transplantation

治疗性血浆置换在ABO血型不相容肝移植中的关键作用

2022-12-018
PRE